Preferred Label : Anti-TREM2 Monoclonal Antibody PY314;
NCIt definition : A humanized monoclonal antibody targeting triggering receptor expressed on myeloid
cells 2 (TREM2; TREM-2), with potential immunomodulating and antineoplastic activities.
Upon administration, anti-TREM2 monoclonal antibody PY314 targets and binds to TREM2
located on immunosuppressive tumor-associated myeloid cells within the tumor microenvironment
(TME), including tumor associated macrophages (TAMs). This induces antibody dependent
cell mediated cytotoxicity (ADCC) and/or antibody dependent cell mediated phagocytosis
(ADCP), thereby killing TREM2-positive cells, including TAMs. The depletion of TAMs
alters the TME, activates cytotoxic T-lymphocytes (CTLs), natural killer (NK) cells
and M1-like macrophages, which stimulate anti-tumor immune responses, and leads to
tumor cell destruction. TREM2, an immunoglobulin (Ig) superfamily transmembrane protein,
is expressed within the TME and is associated with poorer patient outcomes.;
Molecule name : PY-314; PY 314;
NCI Metathesaurus CUI : CL1662172;
Origin ID : C179597;
UMLS CUI : C5555802;
- Semantic type(s)
- chemical_or_drug_has_mechanism_of_action
- concept_is_in_subset
- has_target